Related references
Note: Only part of the references are listed.Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
W. Rigby et al.
ARTHRITIS AND RHEUMATISM (2012)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
Atacicept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate Results of a Phase II, Randomized, Placebo-Controlled Trial
R. F. van Vollenhoven et al.
ARTHRITIS AND RHEUMATISM (2011)
Atacicept in Patients With Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Antagonist Therapy Results of a Phase II, Randomized, Placebo-Controlled, Dose-Finding Trial
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS RESEARCH & THERAPY (2008)
B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling
Fabienne Mackay et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: Pharmacokinetic, pharmacodynamic, and toxicologic effects
Wendy G. Halpern et al.
TOXICOLOGICAL SCIENCES (2006)
The TNF family members BAFF and APRIL: the growing complexity
F Mackay et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Roles of B cells in rheumatoid arthritis
GJ Silverman et al.
ARTHRITIS RESEARCH & THERAPY (2003)
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS
JA Gross et al.
IMMUNITY (2001)
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice
H Wang et al.
NATURE IMMUNOLOGY (2001)
Share Paper
